S&P 500   4,210.24
DOW   33,309.51
QQQ   325.93
The How And Why of Investing in Oil Stocks
The WORST National Security Threat To The USA Since The 1973 Arab Oil Embargo? (Ad)
The How and Why of Investing in Gold Stocks
The 2 Dow Stocks with Decade-Long Win Streaks on the Line
Trump says he took the Fifth in NY civil investigation
Forget Tesla, THIS Could be the Biggest EV Investment Play in 2022 (Ad)
Closing prices for crude oil, gold and other commodities
Wall Street roars after inflation cools more than expected
Rhine River could fall below critical mark, risking industry
Investors Look to Capitalize on the Budding Green Revolution (Ad)
S&P 500   4,210.24
DOW   33,309.51
QQQ   325.93
The How And Why of Investing in Oil Stocks
The WORST National Security Threat To The USA Since The 1973 Arab Oil Embargo? (Ad)
The How and Why of Investing in Gold Stocks
The 2 Dow Stocks with Decade-Long Win Streaks on the Line
Trump says he took the Fifth in NY civil investigation
Forget Tesla, THIS Could be the Biggest EV Investment Play in 2022 (Ad)
Closing prices for crude oil, gold and other commodities
Wall Street roars after inflation cools more than expected
Rhine River could fall below critical mark, risking industry
Investors Look to Capitalize on the Budding Green Revolution (Ad)
S&P 500   4,210.24
DOW   33,309.51
QQQ   325.93
The How And Why of Investing in Oil Stocks
The WORST National Security Threat To The USA Since The 1973 Arab Oil Embargo? (Ad)
The How and Why of Investing in Gold Stocks
The 2 Dow Stocks with Decade-Long Win Streaks on the Line
Trump says he took the Fifth in NY civil investigation
Forget Tesla, THIS Could be the Biggest EV Investment Play in 2022 (Ad)
Closing prices for crude oil, gold and other commodities
Wall Street roars after inflation cools more than expected
Rhine River could fall below critical mark, risking industry
Investors Look to Capitalize on the Budding Green Revolution (Ad)
S&P 500   4,210.24
DOW   33,309.51
QQQ   325.93
The How And Why of Investing in Oil Stocks
The WORST National Security Threat To The USA Since The 1973 Arab Oil Embargo? (Ad)
The How and Why of Investing in Gold Stocks
The 2 Dow Stocks with Decade-Long Win Streaks on the Line
Trump says he took the Fifth in NY civil investigation
Forget Tesla, THIS Could be the Biggest EV Investment Play in 2022 (Ad)
Closing prices for crude oil, gold and other commodities
Wall Street roars after inflation cools more than expected
Rhine River could fall below critical mark, risking industry
Investors Look to Capitalize on the Budding Green Revolution (Ad)
OTCMKTS:GBOKF

Greenbrook TMS - GBOKF Stock Forecast, Price & News

Add
Compare
Today's Range
N/A
50-Day Range
$15.45
$15.45
52-Week Range
N/A
Volume
100 shs
Average Volume
1,572 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
GBOKF stock logo

About Greenbrook TMS (OTCMKTS:GBOKF) Stock

Greenbrook TMS Inc., together with its subsidiaries, operates a network of outpatient mental health services centers in the United States. It offers transcranial magnetic stimulation therapy, an FDA-cleared non-invasive therapy that provides electromagnetic stimulation to brain regions associated with mood regulation for the treatment of major depressive disorder and other mental health disorders. The company operates approximately 121 treatment centers in the United States. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.

Receive GBOKF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Greenbrook TMS and its competitors with MarketBeat's FREE daily newsletter.

GBOKF Stock News Headlines

Greenbrook TMS (OTCMKTS:GBOKF) Shares Down 0.3%
What Wall Street expects from Greenbrook TMS's earnings
Greenbrook TMS COO Roberto Drassinower to resign
Greenbrook TMS Provides Corporate Update
Greenbrook TMS Shares Falter After Planned Stock Sale
Greenbrook TMS earnings: here's what Wall Street expects
Greenbrook TMS Provides Update on Public Offering
Here's what Wall Street expects from Greenbrook TMS's earnings report
Greenbrook to Commence Trading on NASDAQ
Greenbrook TMS Announces Director Resignation
See More Headlines

Receive GBOKF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Greenbrook TMS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Medical Care Facilities
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:GBOKF
CIK
N/A
Fax
N/A
Employees
333
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Bill Leonard (Age 55)
    Pres, CEO & Director
    Comp: $500k
  • Mr. Roberto Drassinower (Age 56)
    Chief Operating Officer
    Comp: $307.5k
  • Ms. Euphia Hsu Smith
    Chief Marketing Officer
  • Mr. Erns Loubser C.A.
    C.F.A., CFO, Treasurer & Corp. Sec. (Leave of Absence)
  • Dr. Geoffrey Grammer M.D.
    Chief Medical Officer
  • Mr. Ed Cordell
    Interim Chief Financial Officer
  • Glen Akselrod
    Investor Relations Officer













GBOKF Stock - Frequently Asked Questions

What is Greenbrook TMS's stock symbol?

Greenbrook TMS trades on the OTCMKTS under the ticker symbol "GBOKF."

How do I buy shares of Greenbrook TMS?

Shares of GBOKF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

How many employees does Greenbrook TMS have?

The company employs 333 workers across the globe.

How can I contact Greenbrook TMS?

The official website for the company is www.greenbrooktms.com. The company can be reached via phone at 416-322-9700.

This page (OTCMKTS:GBOKF) was last updated on 8/11/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.